News
Panelists discuss how treatment decisions in multiple myeloma are guided by disease risk, patient health, and evolving ...
Gail Whiteford wants to raise awareness of the symptoms she suffered to avoid the same happening to other people.
Teclistamab-cqyv (Tecvayli) led to clinically meaningful responses in patients with heavily pretreated multiple myeloma who ...
During a live event, Hans Lee, MD, and participants shared their perspectives on current and upcoming treatment approaches in ...
I’ve endured numerous rounds of radiation and taken thousands of pills—but CAR-T is the most effective therapy I’ve completed ...
The FDA has granted accelerated approval to linvoseltamab-gcpt (Lynozyfic) for the treatment of adult patients with ...
Rapid advances have revolutionized the treatment of multiple myeloma, providing better disease control and prolonging ...
12d
Live Science on MSNChemotherapy can make healthy blood cells 'look old,' study suggestsResearchers have identified ways in which chemotherapy can damage healthy cells and found that some drugs can add decades of ...
Multiple myeloma, a treatable but incurable blood cancer, is rising sharply in India, especially among those over 60. Dr.
A groundbreaking NHS therapy for myeloma uses a 'Trojan horse' approach to target cancer cells, offering longer remission, ...
Carmen Phaneuf has completed multiple triathlons, gone hiking in France, and skied in Iceland, but during all of these adventures, cancer was looming like a storm cloud. Phaneuf, of Little Falls, has ...
Nadine Poormon, diagnosed with multiple myeloma in 2017, participated in a trial that helped Carvykti gain FDA approval. She had tried several drugs before Carvykti ... Poormon found Carvykti less ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results